Teva Drug Would Infringe Mylan Patent, Judge Says
U.S. District Judge Irene M. Keeley said Teva's generic form of Perforomist violates two asserted claims in U.S. Patent Number 6,667,344, held by Mylan Specialty, a subsidiary of Mylan that specializes in manufacturing drugs that treat respiratory diseases.
The '344 patent is one of four patents-in-suit covering Perforomist that will be asserted at an upcoming trial before...
Already a subscriber? Click here to login